| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 100016-73-7 | (6aS-(6aalpha,7alpha,8beta,9aalpha))-2-Amino-1,6,6a,7,8,9a-hexahydro-7-hydroxy-8-(hydroxymethyl)-Formaldehyde | C17H23ClO3 |
| 100016-94-2 | Sesamolinol | C20H20O7 |
| 100017-18-3 | (2R,6R)-6-Methyl-2-(2-Methyl-2-Propanyl)-1,3-Dioxan-4-One | C9H16O3 |
| 100018-95-9 | (1S,3S,4R,5S)-1,3-Bis[[(E)-3-(3,4-Dihydroxyphenyl)Prop-2-Enoyl]Oxy]-4,5-Dihydroxy-Cyclohexane-1-Carboxylate, 2-Hydroxyethyl-Trimethyl-Ammonium | C30H37NO13 |
| 100018-96-0 | Ethyl Iodooctadecanoate | C20H39IO2 |
| 100020-95-9 | Tricyclo[5.4.0.04,8]Undecane-1-Carbonyl Chloride | C12H17ClO |
| 100021-05-4 | (17alpha)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one | C21H28O2 |
| 100021-45-2 | (E)-1-(3-Pyridinyl)-2-Buten-1-One | C9H9NO |
| 100021-46-3 | 3-hydroxy-1-(3-pyridinyl)-1-Butanone | |
| 100021-79-2 | (2-Aminoethyl)Ammonium Palmitate | C18H40N2O2 |
| 100021-80-5 | 2-Aminoethyl-[(Z)-Octadec-9-Enoyl]Ammonium Phosphate | C20H41N2O5P |
| 100021-81-6 | N-(2-Aminoethyl)Stearamide Phosphate | C20H42N2O5P |
| 100021-82-7 | N-(2-Aminoethyl)Palmitamide Phosphate | C18H38N2O5P |
| 100021-84-9 | stearic acid, compound with ethane-1,2-diamine phosphate | C20H47N2O6P |
| 100021-85-0 | Palmitic acid, compound with ethylenediamine phosphate | |
| 100031-76-3 | 1,2-Diphenylvaleroyl-3-Phosphatidylcholine | C30H44NO8P |
| 100032-79-9 | (4-Bromo-2-Nitrophenyl)Hydrazine Hydrochloride (1:1) | C6H7BrClN3O2 |
| 100035-75-4 | Evandamine | C11H16N4S |
| 100036-64-4 | 3'-(Trifluoromethyl)-[1,1'-Biphenyl]-4-Carboxaldehyde | C14H9F3O |
| 100036-74-6 | N6,N6'-[(2,3,5,6-tetrachloro-1,4-phenylene)bis(methylene)]bis[N6-nitroso-2,4,6-Quinazolinetriamine] diacetate | C28H26Cl4N12O6 |
| 100036-97-3 | N-2-Hydroxypropyl-beta-(4,5-Dibromo-2-Furyl)Acrylamide | C10H11Br2NO3 |
| 100036-98-4 | N-Ethoxycarbonylmethyl-beta-(5-Nitro-4-Bromo-2-Furyl)Acrylamide | C11H11BrN2O6 |
| 100037-00-1 | N-(2-N-Piperidinylethyl)-beta-(5-Nitro-4-Bromo-2-Furyl)Acrylamide | C14H18BrN3O4 |
| 100037-69-2 | PIPES sesquisodium salt | C16H33N4Na3O12S4 |
| 100037-71-6 | 7-Methyl-2,3-Dihydrothieno[2,3-c]Pyridine | C8H9NS |
| 100037-76-1 | 7-Isopropylthieno[2,3-c]Pyridine | C10H11NS |
| 100038-00-4 | 2,3-Dihydrospiro[Indene-1,3'-Pyrrolidine]-4,5-Diol | C12H15NO2 |
| 100038-04-8 | 2,3-Dihydrospiro[Indene-1,3'-Pyrrolidine]-5,6-Diol | C12H15NO2 |
| 100038-08-2 | 1,3-Dihydrospiro[Indene-2,2'-Pyrrolidine]-5,6-Diol | C12H15NO2 |
| 100038-54-8 | Iodosulpride | C19H27IN2O4S |
| 100039-07-4 | (5R)-5-Amino-2-Pyrrolidinone | C4H8N2O |
| 100039-63-2 | 4-[(4E)-4-(Indol-1-Ylmethylidene)-2-Methyl-5-Oxo-Imidazol-1-Yl]Benzoic Acid | C20H15N3O3 |
| 100040-31-1 | Gastric inhibitory polypeptide (human) | C226H338N60O66S |
| 100041-05-2 | Flazin | C17H12N2O4 |
| 100043-01-4 | [2,9,16,23-Tetranitro-29H,31H-Tetrabenzoporphinato(2-)-kappa2N29,N31]Zinc | C36H16N8O8Zn |
| 100043-29-6 | 2H-Tetrazole | CH2N4 |
| 100045-68-9 | 2-S-Glutathionylcaffeic Acid | C19H23N3O10S |
| 100045-73-6 | Ulapualide A | C46H64N4O13 |
| 100045-74-7 | 4-O-Acetyl-21-O-De(Aminocarbonyl)-27-Demethoxy-4-O,23,26-Tridemethyl-6-Deoxo-25-Deoxy-6-(2,3-Dimethoxy-1-Oxopropoxy)-27-Methyl-25-Oxokabiramide C | C51H74N4O16 |
| 100045-83-8 | (Methoxymethoxymethyl)tributyltin | C15H34O2Sn |
| 100047-35-6 | 4-Oxo-1,4-Dihydro-2-Pyridinecarboxamide | C6H6N2O2 |
| 100047-36-7 | 4-Aminopyridine-2-carboxylic acid | C6H6N2O2 |
| 100047-42-5 | 1,2-Dihydro-6-(methylthio)-3H-pyrazolo[3,4-d]pyrimidin-3-one | C6H6N4OS |
| 100047-44-7 | 3,4-Dihydropyrimido[5,4-d]Pyrimidine | C6H6N4 |
| 100047-45-8 | 4-Amino-1,7-dihydro-2H-pyrrolo[2,3-d]pyrimidin-2-one | C6H6N4O |
| 100047-52-7 | 5-Methyl-1H-pyrrole-3-carboxylic acid | C6H7NO2 |
| 100047-54-9 | 5-Methyl-4-Isoxazolecarboxylic Acid Methyl Ester | C6H7NO3 |
| 100047-56-1 | 5-Bromo-3-methylpyrazin-2-ol | C5H5BrN2O |
| 100047-61-8 | 4,5-Dimethyl-1,2-Oxazole-3-Carboxylic Acid | C6H7NO3 |
| 100047-65-2 | N-(2-Oxo-1,2-Dihydro-3-Pyridinyl)Formamide | C6H6N2O2 |